Liposomal antineoplastic drugs and uses thereof

Details Liposomal antineoplastic drugs and uses thereof Liposomal antineoplastic drugs and uses thereof

2007-07-17

2007-07-17

Kishore, Gollamudi S. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

Reexamination Certificate

active

09896812

ABSTRACT:
This invention relates to liposomal antineoplastic agents (e.g., camptothecin) compositions and methods of using such compositions for treating neoplasia and for inhibiting angiogenesis. The compositions and methods are useful for modulating the plasma circulation half-life of an active agent.

REFERENCES:
patent: 5023087 (1991-06-01), Yau-Young
patent: 5543152 (1996-08-01), Webb et al.
patent: 5552156 (1996-09-01), Burke
patent: 5741516 (1998-04-01), Webb et al.
patent: 5837282 (1998-11-01), Fenske et al.
patent: 6110491 (2000-08-01), Kirpotin
patent: 6355268 (2002-03-01), Slater
patent: WO 95/08986 (1995-04-01), None
patent: WO 98/17256 (1998-04-01), None
patent: 99/13816 (1999-03-01), None
patent: WO 99/51202 (1999-10-01), None
patent: WO 00/23052 (2000-04-01), None
Burris III et al., “Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro,”Journal of the National Cancer Institute84(23):1816-1820 (1992).
Clements et al., “Antiangiogenic potential of camptothecin and topotecan,”Cancer Chemother. Pharmacol.44:411-416 (1999).
Emerson et al., “In vivoantitumor activity of two new seven-substituted water-soluble camtothecin analogues,”Cancer Research55:603-609 (1995).
Erickson-Miller et al., “Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro,”Cancer Chemother. Pharmacol.39:467-472 (1997).
Grochow et al., “Pharmacokinetics and pharmacodymanics of topotecan in patients with advanced cancer,”Drug Metabolism and Disposition20(5):706-713 (1992).
Hardman et al., “Efficacy of treatment of colon, lung and breast human carcinoma xenografts with: Doxorubicin, cisplatin, irinotecan or topotecan,”Anticancer Research19:2269-2274 (1999).
Hsiang et al., “Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin,”Cancer Research48:1722-1726 (1988).
Madden et al., “The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient; a survey,”Chemistry and Physics of Lipids53:37-46 (1990).
Madden et al., “Encapsulation of topotecan in lipid-based carrier systems. Evaluation of drug stability and plasma elimination in a murine model, and comparison of antitumor efficacy against murine L 1210 and B16 tumors,”Proc. of ASCO, 17:abstract #754 (1998).
Mayer et al., “Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients,”Biochimica et Biophysica Acta1025:143-151 (1990).
McCabe et al., “Comparative activity of oral and parenteral topotecan in murine tumor models: Efficacy of oral topotecan,”Cancer Investigation12(3):308-313 (1994).
O'Leary et al., “Antiangiogenic effects of camptothecin analogues 9-amino-20(S)-camptothecin, topotecan, and CPT-11 studied in the mouse comea model,”Clinical Cancer Research5:181-187 (1999).
Ormrod and Spencer, “Topotecan: A review of its efficacy in small cell lung cancer,”Drugs58(3):533-551 (1999).
Tardi et al., “Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models,”Cancer Research60:3389-3393 (2000).
Thompson et al., “Animal models for studying the action of topoisomerase I targeted drugs,”Biochimica et Biophysica Acta1400:301-319 (1998).
Wall et al., “Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor fromCamptotheca acuminate,” Journal of the American Chemical Society88(16):3888-3890 (1966).

Affiliated with

Also associated with

Rating

Liposomal antineoplastic drugs and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liposomal antineoplastic drugs and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposomal antineoplastic drugs and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3758872